Prosecution Insights
Last updated: October 04, 2026

Alleviant Medical, Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Alleviant Medical, Inc. manages a company patent portfolio in the Medical Devices & Mechanical Engineering technology area. The portfolio currently has 1 pending office action. This workload is assigned to the distinct examiner, which shows a focused prosecution path at the USPTO. This concentration allows the applicant to focus resources on a single point of contact during the examination process.

The busiest examiner for this portfolio is DELLA, JAYMI E, who is responsible for the pending office action. Since this matches the total active count, this examiner is the only individual currently reviewing the company's applications. This concentration means that the prosecution strategy is entirely dependent on the feedback and procedural preferences of DELLA, JAYMI E.

Furthermore, the portfolio's active matters are located within 1 distinct art unit. This indicates that the technical subject matter is currently being evaluated within a single specialized group. For a practitioner, having only this 1 distinct art unit involved simplifies the management of the portfolio, as there is no need to navigate different procedural norms or examination styles across multiple units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DELLA, JAYMI E 1 68.8% +29.9%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17019042 SYSTEMS, DEVICES, AND METHODS FOR FORMING AN ANASTOMOSIS DELLA, JAYMI E 100d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17019042 SYSTEMS, DEVICES, AND METHODS FOR FORMING AN ANASTOMOSIS DELLA, JAYMI E 100d overdue

Top Art Units

Art UnitApps
3794 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17019042 SYSTEMS, DEVICES, AND METHODS FOR FORMING AN ANASTOMOSIS DELLA, JAYMI E 3794 §103§112 Final Rejection 100d overdue Pending Sep 11, 2020

Managing Alleviant Medical, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month